Skip to content
TrialScanner

NCT02531360

Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies

Early Phase 1CompletedLNTHCollaborator

Registry record

Lead sponsor
Molecular NeuroImaging
Conditions
Alzheimer's Disease (AD); Progressive Supranuclear Palsy (PSP); Cortical Basal Syndrome (CBS); Frontal Temporal Dementia (FTD)
Primary completion
Jul 2016Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02531360 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02531360: Evaluation of [18F]MNI-815... | TrialScanner